Harvey Brian Nicholas 4
4 · Adicet Bio, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Harvey Brian Nicholas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-31+324,040→ 324,040 totalExercise: $0.89Exp: 2035-01-30→ Common Stock (324,040 underlying)
Footnotes (1)
- [F1]1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.